iPLAT1: the first-in-human clinical trial of iPSC-derived platelets as a phase 1 autologous transfusion study

Blood. 2022 Dec 1;140(22):2398-2402. doi: 10.1182/blood.2022017296.
No abstract available

Publication types

  • Clinical Trial, Phase I
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Platelets*
  • Humans
  • Induced Pluripotent Stem Cells*
  • Platelet Transfusion
  • Plateletpheresis